Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Douglas

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Plos One|October 4, 2011
Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent mannerJohn Meshki, Steven D Douglas, Mingyue Hu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 26, 2008
Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia/macrophagesXu Wang, Steven D Douglas, Li Song, et al.
Annals of the New York Academy of Sciences|December 17, 2008
Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesisSteven D Douglas, Jian-Ping Lai, Florin Tuluc, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 27, 2009
A sensitive and rapid liquid chromatography-tandem mass spectrometry method for the quantification of the novel neurokinin-1 receptor antagonist aprepitant in rhesus macaque plasma, and cerebral spinal fluid, and human plasma with application in translational NeuroAIDs researchDi Wu, Dustin J Paul, Xianguo Zhao, et al.
Clinical and Vaccine Immunology : CVI|February 6, 2009
Novel method for determination of substance P levels in unextracted human plasma by using acidificationDonald E Campbell, Paula Bruckner, Nancy B Tustin, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2003
Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytesWen-Zhe Ho, Chang-Jiang Guo, Chun-Su Yuan, et al.
Clinical and Diagnostic Laboratory Immunology|January 5, 2002
Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assayJian-Ping Lai, Steven D Douglas, Farida Shaheen, et al.
Annals of Clinical and Translational Neurology|December 26, 2014
Adjuvant therapies for HIV-associated neurocognitive disordersJennifer L McGuire, Jeffrey S Barrett, Heather E Vezina, et al.
Trends in Immunology|May 12, 2009
Neurokinin 1 receptor isoforms and the control of innate immunityFlorin Tuluc, Jian Ping Lai, Laurie E Kilpatrick, et al.
AIDS Research and Human Retroviruses|December 19, 2002
Increased proliferation within T lymphocyte subsets of HIV-infected adolescentsStuart E Starr, Moussa Sarr, Donald E Campbell, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Plos One|October 4, 2011
Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent mannerJohn Meshki, Steven D Douglas, Mingyue Hu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 26, 2008
Neurokinin-1 receptor antagonist (aprepitant) suppresses HIV-1 infection of microglia/macrophagesXu Wang, Steven D Douglas, Li Song, et al.
Annals of the New York Academy of Sciences|December 17, 2008
Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesisSteven D Douglas, Jian-Ping Lai, Florin Tuluc, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 27, 2009
A sensitive and rapid liquid chromatography-tandem mass spectrometry method for the quantification of the novel neurokinin-1 receptor antagonist aprepitant in rhesus macaque plasma, and cerebral spinal fluid, and human plasma with application in translational NeuroAIDs researchDi Wu, Dustin J Paul, Xianguo Zhao, et al.
Clinical and Vaccine Immunology : CVI|February 6, 2009
Novel method for determination of substance P levels in unextracted human plasma by using acidificationDonald E Campbell, Paula Bruckner, Nancy B Tustin, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2003
Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytesWen-Zhe Ho, Chang-Jiang Guo, Chun-Su Yuan, et al.
Clinical and Diagnostic Laboratory Immunology|January 5, 2002
Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assayJian-Ping Lai, Steven D Douglas, Farida Shaheen, et al.
Annals of Clinical and Translational Neurology|December 26, 2014
Adjuvant therapies for HIV-associated neurocognitive disordersJennifer L McGuire, Jeffrey S Barrett, Heather E Vezina, et al.
Trends in Immunology|May 12, 2009
Neurokinin 1 receptor isoforms and the control of innate immunityFlorin Tuluc, Jian Ping Lai, Laurie E Kilpatrick, et al.
AIDS Research and Human Retroviruses|December 19, 2002
Increased proliferation within T lymphocyte subsets of HIV-infected adolescentsStuart E Starr, Moussa Sarr, Donald E Campbell, et al.
Pageof 13